| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |